Non-alcoholic fatty liver disease differential diagnosis: Difference between revisions
Line 39: | Line 39: | ||
|Patient presents with Bronze diabetes, arthritis and | |Patient presents with Bronze diabetes, arthritis and | ||
congestive heart failure. | congestive heart failure. | ||
| | |HFE genetic testing,Ferritin level | ||
and liver biopsy with staining for iron . | |||
|} | |} |
Revision as of 19:47, 11 December 2017
Non-Alcoholic Fatty Liver Disease Microchapters |
Differentiating Non-Alcoholic Fatty Liver Disease from other Diseases |
---|
Diagnosis |
Treatment |
Case studies |
Non-alcoholic fatty liver disease differential diagnosis On the Web |
American Roentgen Ray Society Images of Non-alcoholic fatty liver disease differential diagnosis |
FDA on Non-alcoholic fatty liver disease differential diagnosis |
CDC on Non-alcoholic fatty liver disease differential diagnosis |
Non-alcoholic fatty liver disease differential diagnosis in the news |
Blogs on Non-alcoholic fatty liver disease differential diagnosis |
Directions to Hospitals Treating Non-alcoholic fatty liver disease |
Risk calculators and risk factors for Non-alcoholic fatty liver disease differential diagnosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.
Overview
Differential Diagnosis
CAUSE | CLINICAL FEATURES | LABORATORY TESTS | |
---|---|---|---|
Auto Immune Hepatitis | More commonly in females | Anti-Nuclear Antibodies,Anti Microsomal Antibodies and Anti Smooth Muscle Anti bodies. | |
α1-antitrypsin deficiency | Elevated liver enzyme levels | α1-antitrypsin level and liver biopsy | |
Wilson disease | Neurologic and psychological
features at age 40 years. |
ceruloplasmin level and liver biopsy e.t.c. | |
Hereditary hemochromatosis | Patient presents with Bronze diabetes, arthritis and
congestive heart failure. |
HFE genetic testing,Ferritin level
and liver biopsy with staining for iron . |